📊 Score Breakdown
Offering Ability
65
Cash Runway
0
Float Risk
27
Warrant Exposure
50
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
37%
📉 Score Deterioration
40%
• Score rose 18 points recently (worsening)
💰 Capital Raise
38%
• Active shelf registration ($100M, 30% of market cap)
• Active ATM program with $37M remaining capacity
🔄 Reverse Split
30%
• 50-day avg $1.46 approaching $1 threshold
💹 Market Data
Market Cap$331.57M
Shares Outstanding249.30M
Float187.28M
Cash$53.38M
Debt$2.39M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 13.9% shares (2025Q4 vs prior)
123 institutional holders · 102.18M shares
#1
BROADWOOD CAPITAL INC
49.56M shares
#2
VANGUARD GROUP INC
9.64M shares
#3
Defender Capital, LLC.
6.83M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest25.92M
Days to Cover16.8
% of Float13.8%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2017
EFFECT
EFFECT
Mar 23, 2026
4
INSIDER TRANSACTION
Mar 12, 2026
S-3
SHELF
Mar 11, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for LCTX
📊 LCTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 LCTX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.